214 related articles for article (PubMed ID: 19913883)
1. Long-term outcome of patients with a negative work-up for asymptomatic microhematuria.
Madeb R; Golijanin D; Knopf J; Davis M; Feng C; Fender A; Stephenson L; Messing EM
Urology; 2010 Jan; 75(1):20-5. PubMed ID: 19913883
[TBL] [Abstract][Full Text] [Related]
2. Long-term outcome of hematuria home screening for bladder cancer in men.
Messing EM; Madeb R; Young T; Gilchrist KW; Bram L; Greenberg EB; Wegenke JD; Stephenson L; Gee J; Feng C
Cancer; 2006 Nov; 107(9):2173-9. PubMed ID: 17029275
[TBL] [Abstract][Full Text] [Related]
3. Dipstick urinalysis screening, asymptomatic microhematuria, and subsequent urological cancers in a population-based sample.
Hiatt RA; Ordoñez JD
Cancer Epidemiol Biomarkers Prev; 1994; 3(5):439-43. PubMed ID: 7848421
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis of urologic malignancies in patients with asymptomatic dipstick hematuria: prospective study with 13 years' follow-up.
Mishriki SF; Nabi G; Cohen NP
Urology; 2008 Jan; 71(1):13-6. PubMed ID: 18242356
[TBL] [Abstract][Full Text] [Related]
5. Asymptomatic microscopic hematuria in adults: summary of the AUA best practice policy recommendations.
Grossfeld GD; Wolf JS; Litwan MS; Hricak H; Shuler CL; Agerter DC; Carroll PR
Am Fam Physician; 2001 Mar; 63(6):1145-54. PubMed ID: 11277551
[TBL] [Abstract][Full Text] [Related]
6. Assessment of asymptomatic microscopic hematuria in adults.
Sharp VJ; Barnes KT; Erickson BA
Am Fam Physician; 2013 Dec; 88(11):747-54. PubMed ID: 24364522
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of a bladder cancer screening program using home hematuria testing and molecular markers.
Bangma CH; Loeb S; Busstra M; Zhu X; El Bouazzaoui S; Refos J; Van Der Keur KA; Tjin S; Franken CG; van Leenders GJ; Zwarthoff EC; Roobol MJ
Eur Urol; 2013 Jul; 64(1):41-7. PubMed ID: 23478169
[TBL] [Abstract][Full Text] [Related]
8. The need for repeated urological evaluation in low-risk patients with microscopic hematuria after negative diagnostic work-up.
Pichler R; Heidegger I; Leonhartsberger N; Stöhr B; Aigner F; Bektic J; Horninger W; Steiner H
Anticancer Res; 2013 Dec; 33(12):5525-30. PubMed ID: 24324092
[TBL] [Abstract][Full Text] [Related]
9. Dipstick pseudohematuria: unnecessary consultation and evaluation.
Rao PK; Gao T; Pohl M; Jones JS
J Urol; 2010 Feb; 183(2):560-4. PubMed ID: 20018314
[TBL] [Abstract][Full Text] [Related]
10. Early results of bladder-cancer screening in a high-risk population of heavy smokers.
Steiner H; Bergmeister M; Verdorfer I; Granig T; Mikuz G; Bartsch G; Stoehr B; Brunner A
BJU Int; 2008 Aug; 102(3):291-6. PubMed ID: 18336612
[TBL] [Abstract][Full Text] [Related]
11. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcome of home dipstick testing for hematuria.
Madeb R; Messing EM
World J Urol; 2008 Feb; 26(1):19-24. PubMed ID: 18040694
[TBL] [Abstract][Full Text] [Related]
13. Screening for bladder tumours in men aged 60-70 years with a bladder tumour marker (UBC) and dipstick-detected haematuria using both white-light and fluorescence cystoscopy.
Hedelin H; Jonsson K; Salomonsson K; Boman H
Scand J Urol Nephrol; 2006; 40(1):26-30. PubMed ID: 16452052
[TBL] [Abstract][Full Text] [Related]
14. [The value of urine sediment cytomorphology in the ambulatory differential diagnosis of hematuria].
Obroniecka I; Rojewska J; Wańkowicz Z
Pol Merkur Lekarski; 1998 Nov; 5(29):285-7. PubMed ID: 10101502
[TBL] [Abstract][Full Text] [Related]
15. [Clinical study of asymptomatic microhematuria].
Zama S
Hinyokika Kiyo; 1990 Sep; 36(9):1053-7. PubMed ID: 2239611
[TBL] [Abstract][Full Text] [Related]
16. Can hematuria be a predictor as well as a symptom or sign of bladder cancer?
Friedman GD; Carroll PR; Cattolica EV; Hiatt RA
Cancer Epidemiol Biomarkers Prev; 1996 Dec; 5(12):993-6. PubMed ID: 8959322
[TBL] [Abstract][Full Text] [Related]
17. Routine surveillance cystoscopy for patients with augmentation and substitution cystoplasty for benign urological conditions: is it necessary?
Hamid R; Greenwell TJ; Nethercliffe JM; Freeman A; Venn SN; Woodhouse CR
BJU Int; 2009 Aug; 104(3):392-5. PubMed ID: 19239457
[TBL] [Abstract][Full Text] [Related]
18. Asymptomatic microhematuria: an indication of hereditary hemorrhagic telangiectasia?
Di Gennaro L; Ramunni A; Suppressa P; Guastamacchia E; Resta F; Sabbà C
J Urol; 2005 Jan; 173(1):106-9. PubMed ID: 15592044
[TBL] [Abstract][Full Text] [Related]
19. Comparison of bladder cancer outcome in men undergoing hematuria home screening versus those with standard clinical presentations.
Messing EM; Young TB; Hunt VB; Gilchrist KW; Newton MA; Bram LL; Hisgen WJ; Greenberg EB; Kuglitsch ME; Wegenke JD
Urology; 1995 Mar; 45(3):387-96; discussion 396-7. PubMed ID: 7879333
[TBL] [Abstract][Full Text] [Related]
20. Routine follow-up cystoscopy in detection of recurrence in patients being monitored for bladder cancer.
Raitanen MP; Leppilahti M; Tuhkanen K; Forssel T; Nylund P; Tammela T;
Ann Chir Gynaecol; 2001; 90(4):261-5. PubMed ID: 11820414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
